We are live on
!
Find out more
Fifth Third Bancorp Portfolio holdings
AUM
$54.7B
1-Year Est. Return
26.51%
This Fund
S&P 500
This Quarter
Est. Return
-1.55%
1 Year Est. Return
+26.51%
3 Year Est. Return
+84.46%
5 Year Est. Return
+101.09%
10 Year Est. Return
+314.66%
AUM
$54.7B
AUM Growth
+$23.2B
(+74%)
Cap. Flow
+$25.4B
Cap. Flow
% of AUM
46.46%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
4,357
New
1,699
Increased
2,256
Reduced
166
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$829M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$769M |
| 4 |
Microsoft
MSFT
|
+$711M |
| 5 |
NVIDIA
NVDA
|
+$685M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HNI Corp
HNI
|
+$39.8M |
| 2 |
Accenture
ACN
|
+$21.3M |
| 3 |
Marvell Technology
MRVL
|
+$4.73M |
| 4 |
TSMC
TSM
|
+$3.54M |
| 5 |
Invesco S&P 500 GARP ETF
SPGP
|
+$3.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.77% |
| 2 | Healthcare | 9.53% |
| 3 | Financials | 9.43% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Encompass Health
EHC
$11B
| $3.7M | 0.01% |
38,282
+33,346
| +676% | +$3.42M |
|
902
BridgeBio Pharma
BBIO
$16.2B
| $3.69M | 0.01% |
+49,729
| New | +$3.6M |
|
903
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.84B
| $3.68M | 0.01% |
49,238
+48,666
| +8,508% | +$3.7M |
|
904
Joby Aviation
JOBY
$7.39B
| $3.67M | 0.01% |
444,875
+442,877
| +22,166% | +$4.99M |
|
905
Lincoln National
LNC
$7.84B
| $3.67M | 0.01% |
103,301
+76,942
| +292% | +$2.96M |
|
906
Chemed
CHE
$6.61B
| $3.66M | 0.01% |
9,697
+6,807
| +236% | +$2.92M |
|
907
Pinnacle Financial Partners Inc
PNFP
$14.6B
| $3.66M | 0.01% |
42,514
+41,342
| +3,527% | +$3.85M |
|
908
Williams-Sonoma
WSM
$25.5B
| $3.66M | 0.01% |
20,071
+11,054
| +123% | +$2.21M |
|
909
Boyd Gaming
BYD
$6.37B
| $3.62M | 0.01% |
44,088
+42,614
| +2,891% | +$3.58M |
|
910
CDW
CDW
$16.6B
| $3.61M | 0.01% |
29,852
+21,790
| +270% | +$2.75M |
|
911
AAR Corp
AIR
$5.14B
| $3.61M | 0.01% |
32,978
+32,707
| +12,069% | +$3.52M |
|
912
Neurocrine Biosciences
NBIX
$17.5B
| $3.61M | 0.01% |
27,393
+26,529
| +3,070% | +$3.52M |
|
913
iShares Global Tech ETF
IXN
$8.85B
| $3.61M | 0.01% |
36,071
+29,645
| +461% | +$3.13M |
|
914
Bio-Rad Laboratories Class A
BIO
$8.36B
| $3.6M | 0.01% |
12,932
+6,175
| +91% | +$1.78M |
|
915
Oshkosh
OSK
$9.52B
| $3.6M | 0.01% |
24,461
+23,310
| +2,025% | +$3.63M |
|
916
Global Payments
GPN
$21.3B
| $3.59M | 0.01% |
53,291
+36,799
| +223% | +$2.71M |
|
917
iShares Semiconductor ETF
SOXX
$45.9B
| $3.58M | 0.01% |
+10,900
| New | +$3.72M |
|
918
Revvity
RVTY
$12.4B
| $3.57M | 0.01% |
40,784
+37,181
| +1,032% | +$3.68M |
|
919
Match Group
MTCH
$8.66B
| $3.57M | 0.01% |
116,306
+109,497
| +1,608% | +$3.41M |
|
920
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.56M | 0.01% |
62,991
+62,183
| +7,696% | +$3.63M |
|
921
Rocket Lab Corp
RKLB
$43.4B
| $3.55M | 0.01% |
55,214
+53,840
| +3,918% | +$4.06M |
|
922
Gentex
GNTX
$5B
| $3.55M | 0.01% |
162,270
+156,128
| +2,542% | +$3.62M |
|
923
JB Hunt Transport Services
JBHT
$26.9B
| $3.53M | 0.01% |
16,636
+12,286
| +282% | +$2.62M |
|
924
Medpace
MEDP
$17.3B
| $3.52M | 0.01% |
7,338
+6,956
| +1,821% | +$3.56M |
|
925
Armstrong World Industries
AWI
$6.69B
| $3.52M | 0.01% |
21,348
+20,419
| +2,198% | +$3.73M |
|
Similar funds
Fifth Third Bancorp's Q1 2026 Portfolio in Review
As of Q1 2026, Fifth Third Bancorp held 4,357 positions worth $54.7B, up 74% from $31.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fifth Third Bancorp deployed $25.4B of net new capital in Q1 2026, opening 1,699 new positions and adding to 2,256 existing holdings. Its largest new stake was Fidelity Enhanced Small Cap Core ETF: 2,784,388 shares worth $106M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was HNI Corp, an estimated $39.8M trimmed.
- Fifth Third Bancorp's largest Q1 2026 buy was Fidelity Enhanced Small Cap Core ETF: 2,784,388 shares worth $106M.
- Fifth Third Bancorp added most to Eli Lilly in Q1 2026, an estimated $1.52B increase.
- Fifth Third Bancorp's biggest Q1 2026 reduction was HNI Corp, cutting an estimated $39.8M.
- Fifth Third Bancorp fully exited Hillenbrand in Q1 2026, selling an estimated $2.54M.
- Fifth Third Bancorp's ten largest holdings make up 29% of its $54.7B portfolio in Q1 2026.
- Fifth Third Bancorp opened 1,699 new positions and closed 54 in Q1 2026.
- Fifth Third Bancorp's portfolio value rose 74% quarter-over-quarter to $54.7B.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.